PSYC’s CEO to Moderate Panel
at Film Screening for ESPN’s Upcoming Documentary, "Peace of
Mind"
LAS VEGAS, NV -- March 29, 2023 -- InvestorsHub NewsWire -- PSYC
Corporation (OTC
Pink Market: PSYC) (“PSYC”, “PSYC Corp” or the “Company”),
parent company to Spotlight
Media Corporation (“SMC” or the “wholly owned subsidiary”), a
multimedia leader positioned at the intersection where all things
psychedelics and cannabis converge, is pleased to announce that
PSYC CEO, David Flores, will participate in the Penn Psychedelics
Collaborative (the “PPC”) film screening event, “Psychedelics &
the Road to Recovery,” which will feature a special screening of
"Peace of Mind", a new documentary produced by ESPN highlighting
the potential benefits of psychedelic-assisted therapy for
traumatic brain injury (“TBI”) and mental health disorders, to be
held at the Perelman School of Medicine on the University of
Pennsylvania campus on Sunday, April 23rd.
Following the film screening, the PPC will host a panel
discussion with experts in the fields of neurology, TBI research,
psychedelic-assisted therapy, and policy moderated by David Flores.
Panelists will discuss the potential benefits of psychedelics in
the treatment of traumatic brain injury, pathology and recovery in
humans, drug development and treatment strategies, the current
state of research and regulatory policy, and ethical considerations
of using psychedelics in a therapeutic setting.
The documentary, which will air nationally on ESPN on Saturday,
April 22nd, explores the experiences of former NFL and NHL players,
such as Riley Cote, who will be in attendance at the film
screening, who suffered from TBI and mental health disorders and
turned to psychedelic-assisted therapy, specifically with
psilocybin, in hopes of improving their mental and physical
wellbeing. Moreover, the film examines the promising results of
psychedelic-assisted therapy and its potential as a viable
treatment for these debilitating conditions.
This event is open to the public and will take place on Sunday,
April 23rd, 2023, at the University of Pennsylvania’s Perelman
School of Medicine's Clinical Research Building auditorium. Doors
open at 2:00 pm and the event begins promptly at 2:30 pm. Attendees
should register in advance through the Eventbrite link provided
below.
www.wake.net/espn
As a moderator for the panel discussion, Mr. Flores will be
representing PSYC’s Psychedelic
Spotlight, a top 3 globally ranked psychedelic-focused
multimedia platform.
“I’m truly honored to have this wonderful opportunity to
represent PSYC and Psychedelic Spotlight as a moderator for what is
certain to be a highly educational and information-packed panel
discussion regarding the potential benefits of psychedelics in the
treatment of TBI and other debilitating mental health conditions,”
said Mr. Flores.
“Since launching Psychedelic Spotlight nearly 3 years ago, one
of our primary objectives has been to be at the forefront of this
exciting new paradigm shift involving psychedelic-assisted therapy.
Events just like this offer PSYC unique opportunities to be visible
leaders of this positive disruption to old, ineffective,
inefficient, and overly expensive healthcare models and to foster
new conversations without old stigmas. In my opinion, this is yet
another demonstration of our commitment to further solidifying
PSYC’s position as a news, information, and resource leader for
this growing community of psychedelic-inspired healing.
We are incredibly grateful for our friends at The Spore
Group for all of the fantastic work they did in helping to
bring this event together alongside the Penn Psychedelics
Collaborative, Wake, Reason for Hope, and the VA Center for
Neurotrauma, Neurodegeneration and Restoration and look forward to
hosting an inspirational event.”
"We hope this event will spark meaningful conversation and
increase awareness of the early evidence that demonstrates how
psychedelics can be used to treat TBI and related disorders on a
physiological level,” said Mia Lowry, Director of Outreach for The
Spore Group.
A second screening event will also be held on Wednesday, April
26th at Cooper University Health Care. This event will also feature
Riley Cote as a speaker along with experts in the field of
neuromodulation therapies for mental health disorders and pain
management.
Information and tickets for the Cooper University Health Care
screening event may be found at the link below:
https://events.cooperhealth.org/event/community-health-seminars/peace-of-mind-an-espn-documentary-screening
About PSYC Corporation (OTC Pink Market: PSYC)
PSYC Corporation (the “Company” or “PSYC”) is a
forward-thinking multimedia leader for progressive and emerging
market sectors such as medicinal psychedelics and cannabis.
Management’s assessment is that through the diversified
collection of multimedia platforms the Company owns and operates,
and most specifically through the news, information, and engaging
content they each produce and publish respectively, PSYC has
effectively positioned itself at the forefront of some of today’s
most dynamic and opportunity-filled market sectors.
About Spotlight Media Corporation
Spotlight Media Corporation (“SMC”) (www.spotlightmediacorp.com)
is a Nevada Corporation and is a privately held wholly owned
subsidiary of PSYC that was incorporated on February 8, 2022.
SMC currently owns and operates Psychedelic Spotlight which,
according to the Company, has emerged as a recognized
industry-leading multimedia platform dedicated to covering the
growing movement across society involving psychedelic-assisted
healing. Additionally, SMC also operates Bonfire, a
community-focused, consumer-facing platform being developed to
effectively meet the demands linked to the expanding interest and
curiosity across society related to the healing and therapeutic
wonders of psychedelics and other plant based and holistic
modalities.
SMC’s service-focused media platforms include Technical 420, On the
Bids, and Mushroom
Stocks which each serve publicly traded companies operating in
the sectors of cannabis, mining and precious metals, and medicinal
psychedelics and have become valuable informational resources for
individuals following each of these respective market sectors.
Forward-Looking Statements Disclaimer:
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. In some cases, you can identify forward-looking statements
by the following words: "anticipate," "believe," "continue,"
"could," "estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology,
although not all forward-looking statements contain these words.
Forward-looking statements are not a guarantee of future
performance or results and will not necessarily be accurate
indications of the times at, or by, which such performance or
results will be achieved. Forward-looking statements are based on
information available at the time the statements are made and
involve known and unknown risks, uncertainty and other factors,
including the effect of COVID-19 and the success of the current
vaccine distribution, the adverse effect of the Omicron variant,
that may cause our results, levels of activity, performance or
achievements to be materially different from the information
expressed or implied by the forward-looking statements in this
press release. This press release should be considered in light of
all filings of the Company that are disclosed on the OTC
Markets.com website and is not incorporated by reference into such
reports.
Disclaimer: PSYC Corporation does not in any way encourage
or condone the use, purchase, sale or transfer of any illegal
substances, nor do we encourage or condone partaking in any
unlawful activities. We support a harm reduction approach for the
purpose of education and promoting individual and public safety. If
you are choosing to use psychedelic substances, please do so
responsibly.
Corporate Contact:
PSYC Corporation (PSYC)
www.psyccorporation.com
www.spotlightmediacorp.com
(702) 239-1919
info@psyccorporation.com
OTC
PINK MARKET: PSYC
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Oct 2024 to Nov 2024
PSYC (PK) (USOTC:PSYC)
Historical Stock Chart
From Nov 2023 to Nov 2024
